MZL
Clinical trials for MZL explained in plain language.
Never miss a new study
Get alerted when new MZL trials appear
Sign up with your email to follow new studies for MZL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lymphoma treatment showdown: which drug combo wins?
Disease control Not yet recruitingThis study looks at three different drug combinations for people newly diagnosed with a slow-growing blood cancer called marginal zone lymphoma. The goal is to see which combination works best to shrink tumors and keep the cancer from coming back, while also checking for side eff…
Matched conditions: MZL
Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pill shows promise for Hard-to-Treat lymphoma patients
Disease control Not yet recruitingThis Phase 2 trial tests lisaftoclax, an oral drug that blocks a protein helping cancer cells survive. It enrolls 75 adults with certain slow-growing lymphomas (CLL, WM, or MZL) who either cannot take standard BTK inhibitors due to health issues or have stopped them due to side e…
Matched conditions: MZL
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC